1H-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent PARP inhibitors

Details for Australian Patent Application No. 2012200399 (hide)

Owner Abbott Laboratories

Inventors Zhu, Guidong; Gong, Jianchun; Gandhi, Virajkumar B.; Giranda, Vincent; Penning, Thomas D.

Agent Spruson & Ferguson

Pub. Number AU-A-2012200399

Parent 2006235492

Filing date 23 January 2012

Wipo publication date 16 February 2012

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4184 (2006.01)

A61K 31/454 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

9 February 2012 Complete Application Filed

16 February 2012 Application Open to Public Inspection

  Published as AU-A-2012200399

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012200400-Human-machine dialog system

2012200398-1H-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent PARP inhibitors